Wei-Jin Zang Selected Research

Lipid Metabolism Disorders (Metabolism Disorders, Lipid)

4/2019	[Recent progress on obesity-induced myocardial remodeling and its possible mechanism of mitochondrial dyshomeostasis].
4/2018	Pyridostigmine protects against cardiomyopathy associated with adipose tissue browning and improvement of vagal activity in high-fat diet rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wei-Jin Zang Research Topics

Disease

12	Hypoxia (Hypoxemia) 01/2018 - 07/2005
7	Myocardial Infarction 05/2014 - 08/2010
6	Fibrosis (Cirrhosis) 01/2021 - 05/2014
6	Heart Failure 01/2021 - 12/2006
6	Ischemia 04/2015 - 10/2006
6	Reperfusion Injury 05/2013 - 10/2007
5	Infarction (Infarctions) 05/2014 - 01/2011
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 06/2012
4	Cardiomegaly (Heart Hypertrophy) 01/2021 - 01/2017
4	Inflammation (Inflammations) 01/2020 - 07/2014
4	Necrosis 01/2014 - 10/2007
4	Thrombosis (Thrombus) 06/2013 - 04/2006
3	Hypertrophy 01/2021 - 01/2019
3	Hypertension (High Blood Pressure) 01/2020 - 03/2013
3	Mitochondrial Diseases (Mitochondrial Disease) 12/2019 - 01/2019
3	Body Weight (Weight, Body) 04/2019 - 12/2006
3	Myocardial Ischemia (Ischemic Heart Diseases) 11/2012 - 10/2006
2	Diabetic Cardiomyopathies 01/2021 - 11/2008
2	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 04/2019 - 04/2018
2	Obesity 04/2019 - 04/2019
2	Atrial Fibrillation 12/2014 - 10/2012
2	Cardiac Arrhythmias (Arrythmia) 10/2012 - 06/2012
1	Vascular Remodeling 11/2020
1	Infections 12/2019
1	Insulin Resistance 01/2019
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019
1	Cardiomyopathies (Cardiomyopathy) 04/2018
1	Alveolar Bone Loss 07/2016
1	Periodontitis 07/2016
1	Vascular System Injuries 12/2015
1	Liver Cirrhosis (Hepatic Cirrhosis) 10/2015

Drug/Important Bio-Agent (IBA)

15	Acetylcholine (Acetylcholine Chloride)FDA Link 12/2019 - 10/2006
8	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2011
7	Pyridostigmine Bromide (Pyridostigmine)FDA LinkGeneric 01/2021 - 05/2014
6	Cholinergic Agents (Cholinergics)IBA 04/2019 - 08/2008
5	Angiotensin IIIBA 01/2019 - 11/2008
5	Cholinesterases (Cholinesterase)IBA 01/2019 - 12/2006
5	Neurotransmitter Agents (Neurotransmitter)IBA 04/2015 - 04/2011
4	Choline (Choline Chloride)IBA 01/2021 - 12/2015
4	salicylhydroxamic acid (SHAM)IBA 07/2016 - 11/2011
4	CytokinesIBA 07/2014 - 02/2010
4	Peptides (Polypeptides)IBA 07/2014 - 11/2011
3	CalciumIBA 01/2021 - 06/2012
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 04/2011
3	Adenosine Triphosphate (ATP)IBA 01/2021 - 01/2011
3	LipidsIBA 04/2019 - 02/2010
3	Glucose (Dextrose)FDA LinkGeneric 04/2019 - 07/2005
3	CollagenIBA 12/2017 - 05/2014
3	SolutionsIBA 04/2015 - 07/2005
3	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 03/2014 - 10/2007
2	TRPC6 Cation ChannelIBA 01/2021 - 01/2018
2	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 11/2020 - 01/2011
2	EnzymesIBA 01/2020 - 10/2015
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2020 - 01/2012
2	Protein Isoforms (Isoforms)IBA 01/2020 - 11/2011
2	Toll-Like Receptors (Toll-Like Receptor)IBA 08/2016 - 07/2016
2	p38 Mitogen-Activated Protein KinasesIBA 07/2016 - 04/2011
2	Messenger RNA (mRNA)IBA 04/2015 - 04/2011
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2015 - 04/2011
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 07/2014 - 01/2014
2	Phosphotransferases (Kinase)IBA 05/2014 - 10/2007
2	Adenosine Diphosphate (ADP)IBA 03/2014 - 11/2011
2	Fibrinolytic Agents (Antithrombotic Agents)IBA 06/2013 - 01/2012
2	NADPH Oxidases (NAD(P)H oxidase)IBA 11/2012 - 11/2011
2	Creatine Kinase (Creatine Phosphokinase)IBA 03/2012 - 05/2011
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2012 - 12/2006
2	Adenosine (Adenocard)FDA LinkGeneric 01/2011 - 11/2006
2	Adenine FDA LinkGeneric 01/2011 - 01/2011
2	Sulfates (Sulfates, Inorganic)IBA 01/2011 - 01/2011
2	Lactic Acid (Lactate)FDA LinkGeneric 11/2008 - 07/2005
1	Streptozocin (Streptozotocin)FDA Link 01/2021
1	Branched-Chain Amino AcidsIBA 01/2021
1	baojiIBA 01/2020
1	SaltsIBA 01/2020
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2020
1	ProstaglandinsIBA 01/2020
1	PalmitatesIBA 12/2019
1	Blood Glucose (Blood Sugar)IBA 04/2019
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 01/2019
1	Insulin (Novolin)FDA Link 01/2019
1	Nuclear Proteins (Protein, Nuclear)IBA 01/2019
1	Transient Receptor Potential ChannelsIBA 01/2018
1	CationsIBA 01/2018
1	PNU-282987IBA 12/2017
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2017
1	AcetylcholinesteraseIBA 01/2017
1	CalcineurinIBA 01/2017
1	Myosin Heavy Chains (Myosin Heavy Chain)IBA 01/2017
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2017
1	Atrial Natriuretic Factor (ANF)IBA 01/2017
1	HMGB1 Protein (HMG1)IBA 07/2016
1	baicalinIBA 07/2016
1	Toll-Like Receptor 2IBA 07/2016
1	Cholinergic ReceptorsIBA 12/2015
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 12/2015
1	AntioxidantsIBA 10/2015
1	Carbon Tetrachloride (Tetrachloromethane)IBA 10/2015

Therapy/Procedure

6	Therapeutics 01/2022 - 11/2011
2	Vagus Nerve Stimulation 11/2012 - 01/2012
2	Microbubbles 01/2012 - 04/2006